Video Abstract

Video Abstract

Close modal
BACKGROUND

Previous evaluations of medication dosing variance for children in the prehospital setting have been limited regionally or to specific conditions. We sought to describe pediatric dosing deviations from nationally recommended guidelines for commonly administered medications from a registry of prehospital encounters.

METHODS

We evaluated prehospital patient care records for children (<18 years) from approximately 2000 emergency medical services agencies from 2020 to 2021. We investigated dosing deviations (defined as being ≥20% of the weight-appropriate dose from national guidelines) for the following: lorazepam, diazepam, and midazolam for seizures; fentanyl, hydromorphone, morphine, and ketorolac; intramuscular epinephrine and diphenhydramine for children with allergy or anaphylaxis; intravenous epinephrine; and methylprednisolone.

RESULTS

Of 990 497 pediatric encounters, 63 963 (6.4%) received at least 1 nonnebulized medication. Among nonnebulized doses, 53.9% were for the studied drugs. Among encounters who received a study drug and which had a documented weight (80.3%), the overall consistency with national guidelines was 42.6 per 100 administrations. Appropriate dosing was most common with methylprednisolone (75.1%), intramuscular epinephrine (67.9%), and ketorolac (56.4%). Medications with the lowest consistency with national guidelines were diazepam (19.5%) and lorazepam (21.2%). Most deviations represented an underdose, which was greatest with lorazepam (74.7%) and morphine (73.8%). Results were similar when estimating dosages from weights calculated by age.

CONCLUSIONS

We identified variance in weight-based dosing from national guidelines for common pediatric medications in the prehospital setting, which may be attributable to protocol differences or dosing errors. Addressing these should be a target for future educational, quality improvement, and research activities.

What’s Known on This Subject:

The appropriate dosing of medications for children in the prehospital setting is increasingly recognized as a quality improvement and research priority. Correct medication dosing is essential to emergency pediatric care and has implications for improving outcomes and avoiding adverse events.

What This Study Adds:

In this evaluation of US emergency medical services agencies, pediatric drug dosing deviations in the prehospital setting from national guidelines were common. Deviations most frequently occurred with benzodiazepines and morphine. Most deviations represented an underdose, especially for sedating medications.

Children comprise a minority (5% to 10%) of patients encountered by emergency medical services (EMS) clinicians.13  The care provided to children in this setting is complicated by their unique physiology with distinct presenting conditions,4,5  their relative infrequency compared with adults,13  and the limited training provided to clinicians on pediatric care and protocols.6,7  In turn, these factors contribute to clinician discomfort with this population.710  Recognizing this challenge, stakeholders such as the American Academy of Pediatrics, American College of Emergency Physicians, Emergency Nurses Association, National Association of EMS Physicians (NAEMSP) and National Association of Emergency Medical Technicians have placed a growing emphasis on pediatric prehospital readiness within EMS systems.11  Among the priorities proposed in this technical report included practices to reduce pediatric medication errors and to develop pediatric-specific measures in quality improvement and quality assurance processes.11 

The correct dosing of medications in the prehospital setting is essential to emergency pediatric care and has implications for both improving outcomes and avoiding adverse events. It is critical to ensure dosing for pediatric conditions remains consistent with evidence-based guidelines. For example, inadequate dosing of abortive seizure medications may fail to stop a seizure.12,13  Both a high or low dose of seizure medications may risk respiratory failure.13,14  Similarly, recent work has suggested that the prehospital administration of steroids in children with asthma may improve clinical outcomes following hospital arrival, including reduced hospitalization and length of stay.15  An incomplete dose of steroids for asthma may therefore result in suboptimal improvement of respiratory function, impacting emergency department disposition. Prior work evaluating deviations or errors in pediatric prehospital dosing have been limited to specific disease states (eg, seizures)1622  and have been primarily regional in nature.1620,2325 

Evaluations of variance in dosing of medications for prehospital pediatric patients compared with clinical guidelines and efforts to minimize dosing errors across large EMS systems remain limited. We sought to describe deviations from nationally recommended dosing of common medications administered to children using a large representative registry of prehospital encounters.

We performed a retrospective cohort study using deidentified prehospital patient care records from the 2020 to 2021 ESO Data Collaborative (Austin, TX). The ESO Data Collaborative is a large dataset of electronic health records from approximately 2000 US-based EMS agencies.26  The dataset includes data on dispatch, demographics, clinical presentation, vital signs, assessments, and interventions performed by EMS clinicians. A standard dataset is created annually for research purposes and is available at no cost following a research proposal process. This study was approved by ESO and by the Ann & Robert H. Lurie Children’s Hospital of Chicago Institutional Review Board. We included all pediatric (<18 years) EMS encounters during the study period who received at least 1 nonnebulized medication. We excluded encounters without a reported age.

We investigated the following 10 drugs: lorazepam, diazepam, midazolam, fentanyl, hydromorphone, morphine, ketorolac, epinephrine, diphenhydramine, and methylprednisolone. Of these, dosing for some medications (benzodiazepines, diphenhydramine, and epinephrine) could be used for multiple indications. For benzodiazepines, we limited our evaluations to encounters with an impression of seizures. For diphenhydramine, we limited our evaluation to patients with an impression of allergy or anaphylaxis. Given the substantially different uses of epinephrine based on indication, this medication was considered in 2 ways: as an intravenous (IV) and as an intramuscular (IM) drug. IM epinephrine was only evaluated for patients with a clinician impression of allergy or anaphylaxis.

We acquired the following descriptive variables of our sample: age, sex, type of service (advanced life support [ALS], basic life support, or critical care), transport disposition, agency status (volunteer, nonvolunteer, or mixed), agency type (community nonprofit, fire department, governmental nonfire, private nonhospital, and tribal), and primary and secondary clinician impressions.

We used 2 reference standards for medication dosing, accounting for differences in dosing by route and maximum doses. For the epinephrine, we considered appropriate dosing to be from the Pediatric Advanced Life Support (PALS) guidelines, which provides nationally recognized dosing recommendations of this drug for both cardiac arrest and anaphylaxis.27  For the other 9 medications, we used dosing recommendations from the National Association of State EMS Officials (NASEMSO) Model EMS Clinical Guidelines.28  The NASEMSO guidelines are produced by a multistakeholder panel, including the NAEMSP, the American College of Emergency Physicians, and the American Academy of Pediatrics Committee on Pediatric Emergency Medicine. Importantly, the NASEMSO guidelines do not provide a dosing range for medications and instead recommend a fixed weight-based dose with maximums (for example, instead of recommending 0.25–0.5 mg/kg to a maximum of 30 mg for IV ketorolac,29  the NASEMSO guidelines recommend 0.5 mg/kg to a maximum of 15 mg without a range28 ). This is consistent with EMS protocols that provide standing orders from EMS medical directors to EMS clinicians for specific indications (Table 1).30,31 

TABLE 1

Dosages Considered as Appropriate

DrugDoseReference
Lorazepam 0.1 mg/kg IV or IO (maximum 4 mg) NASEMSO 
Diazepam 0.2 mg/kg IV or IO (maximum 10 mg) or 0.2 mg/kg PR (maximum 20 mg) NASEMSO 
Midazolam 0.1 mg/kg IV or IO (maximum 4 mg) or 0.2 mg/kg IM/IN (maximum 10 mg) NASEMSO 
Morphine 0.1 mg/kg IM, IV, or IO (maximum 10 mg) NASEMSO 
Hydromorphone 0.015 mg/kg IM, IV, or IO (maximum 2 mg) NASEMSO 
Ketorolac 0.5 mg/kg (maximum 30 mg IM or 15 mg IV) NASEMSO 
Fentanyl 1 mcg/kg IN, IM, IV, or IO (maximum 100 mcg) NASEMSO 
Epinephrine, intramuscular 0.01 mg/kg IM (maximum 0.3 mg); or 0.15 mg for <30 kg and 0.30mg for ≥30 kg PALS 
Diphenhydramine 1 mg/kg IV, IO, IM, or PO (maximum 25 mg) NASEMSO 
Epinephrine, intravenous 0.01 mg/kg IV or IO (maximum 1 mg) PALS 
Methylprednisolone 2 mg/kg IV or IO (maximum 125 mg) NASEMSO 
DrugDoseReference
Lorazepam 0.1 mg/kg IV or IO (maximum 4 mg) NASEMSO 
Diazepam 0.2 mg/kg IV or IO (maximum 10 mg) or 0.2 mg/kg PR (maximum 20 mg) NASEMSO 
Midazolam 0.1 mg/kg IV or IO (maximum 4 mg) or 0.2 mg/kg IM/IN (maximum 10 mg) NASEMSO 
Morphine 0.1 mg/kg IM, IV, or IO (maximum 10 mg) NASEMSO 
Hydromorphone 0.015 mg/kg IM, IV, or IO (maximum 2 mg) NASEMSO 
Ketorolac 0.5 mg/kg (maximum 30 mg IM or 15 mg IV) NASEMSO 
Fentanyl 1 mcg/kg IN, IM, IV, or IO (maximum 100 mcg) NASEMSO 
Epinephrine, intramuscular 0.01 mg/kg IM (maximum 0.3 mg); or 0.15 mg for <30 kg and 0.30mg for ≥30 kg PALS 
Diphenhydramine 1 mg/kg IV, IO, IM, or PO (maximum 25 mg) NASEMSO 
Epinephrine, intravenous 0.01 mg/kg IV or IO (maximum 1 mg) PALS 
Methylprednisolone 2 mg/kg IV or IO (maximum 125 mg) NASEMSO 

IO, intraosseous; PO, oral; PR, per rectal.

Among all encounters, we identified the proportion who received at least 1 nonnebulized medication. We identified encounters who received a study drug and identified the number and percent of encounters who had a weight recorded among these. We calculated the ideal dose of each medication for each encounter in 2 ways. First, in encounters which had a weight (in kilograms) available within the ESO dataset, we calculated the appropriate weight-based dose. Second, as not all encounters had a documented weight, we estimated weight from age using the “Best-Guess” formula, which has been previously demonstrated to have greater accuracy for age-based weight estimation compared with other techniques.32,33  We defined a medication dosing deviation as being ≥20% from the ideal weight-appropriate dose on the basis of previous literature evaluating dosing errors in children.2325,34  For drugs with different routes of delivery, we evaluated dosing deviations within these subgroups, combining together IV and intraosseous routes. We stratified our findings among the 3 major agency types (community nonprofit, fire, and government nonfire) and 2 major agency statuses (nonvolunteer and mixed). As post hoc exploratory analyses, we repeated our analysis for (A) methylprednisolone on the sample of patients with asthma and allergy or anaphylaxis on their primary or secondary impression and for (B) IV epinephrine on the sample of patients with a primary or secondary impression of cardiac arrest. Analyses were performed using R, version 4.1.2 (R Foundation for Statistical Computing, Vienna, Austria).

20 929 045 records were identified over the 2-year period. After applying exclusions, we identified 990 497 children. Of these, 63 963 (6.4%) received at least 1 nonnebulized medication (Fig 1). Among this sample, the median age was 13.4 years (interquartile range 5.5–16.2 years), and 54.9% were boys. Most encounters were treated by an ALS provider (93.8%) and were transported to the hospital (91.7%). Demographics of the included sample are provided in Table 2.

FIGURE 1

Selection of pediatric emergency medical services encounters.

FIGURE 1

Selection of pediatric emergency medical services encounters.

Close modal
TABLE 2

Characteristics of Encounters Who Received a Nonnebulized Medication (N = 63 963)

VariableN (%) or Median (IQR)
Age, years 13.4 (5.47–16.2) 
Male sex 35 119 (54.9) 
Level of care  
 ALS 60 021 (93.8) 
 BLS 1114 (1.7) 
 Critical care 2002 (3.1) 
Transported to the hospital 58 663 (91.7) 
Location  
 Home or residence 34 706 (54.3) 
 Street or highway 6659 (10.4) 
 School 5735 (9.0) 
 Hospital 4725 (7.4) 
 Others 12 137 (19.0) 
Agency status  
 Nonvolunteer 50 419 (78.8) 
 Volunteer 465 (0.7) 
 Mixed 13 072 (20.4) 
Agency type  
 Community, nonprofit 30 508 (47.7) 
 Fire department 13 923 (21.8) 
 Governmental, nonfire 13 511 (21.1) 
 Private, nonhospital 4398 (6.9) 
 Hospital 1579 (2.5) 
 Tribal 44 (0.1) 
Primary impression  
 Injury, not otherwise specified 6985 (10.9) 
 Seizures 5722 (8.9) 
 Allergic reaction 4298 (6.7) 
 Febrile seizures 2866 (4.5) 
 Cardiac arrest 2634 (4.1) 
 Injury of lower leg 2226 (3.5) 
 Abdominal pain 2214 (3.5) 
 Fever 2168 (3.4) 
 Acute respiratory distress (dyspnea) 1745 (2.7) 
 Behavioral or psychiatric episode 1625 (2.5) 
 Seizures with status epilepticus 1526 (2.4) 
 Altered mental status 1454 (2.3) 
 Injury of head 1391 (2.2) 
 Overdose 1321 (2.1) 
 Other 25 733 (40.2) 
VariableN (%) or Median (IQR)
Age, years 13.4 (5.47–16.2) 
Male sex 35 119 (54.9) 
Level of care  
 ALS 60 021 (93.8) 
 BLS 1114 (1.7) 
 Critical care 2002 (3.1) 
Transported to the hospital 58 663 (91.7) 
Location  
 Home or residence 34 706 (54.3) 
 Street or highway 6659 (10.4) 
 School 5735 (9.0) 
 Hospital 4725 (7.4) 
 Others 12 137 (19.0) 
Agency status  
 Nonvolunteer 50 419 (78.8) 
 Volunteer 465 (0.7) 
 Mixed 13 072 (20.4) 
Agency type  
 Community, nonprofit 30 508 (47.7) 
 Fire department 13 923 (21.8) 
 Governmental, nonfire 13 511 (21.1) 
 Private, nonhospital 4398 (6.9) 
 Hospital 1579 (2.5) 
 Tribal 44 (0.1) 
Primary impression  
 Injury, not otherwise specified 6985 (10.9) 
 Seizures 5722 (8.9) 
 Allergic reaction 4298 (6.7) 
 Febrile seizures 2866 (4.5) 
 Cardiac arrest 2634 (4.1) 
 Injury of lower leg 2226 (3.5) 
 Abdominal pain 2214 (3.5) 
 Fever 2168 (3.4) 
 Acute respiratory distress (dyspnea) 1745 (2.7) 
 Behavioral or psychiatric episode 1625 (2.5) 
 Seizures with status epilepticus 1526 (2.4) 
 Altered mental status 1454 (2.3) 
 Injury of head 1391 (2.2) 
 Overdose 1321 (2.1) 
 Other 25 733 (40.2) 

Sex missing in 99 (0.2%), level of care in 453 (0.7%), and agency status in 7 (<0.1%).

Among all nonnebulized doses administered, 53.9% were of the selected studied drugs. Most patients who received a study drug had a documented initial dose provided that could be used to compare it to the ideal weight-based dose (Table 3). A documented weight was present for 80.3% of children who received a study drug; this was highest for fentanyl (83.0%) and lowest for IM epinephrine (71.8%).

TABLE 3

Counts of Encounters Who Received a Medication

DrugTotal Number of PatientsNumber With Sufficient Data for Dose Calculation (%)Number With Available Weight for Dose Calculation (%)
Lorazepam (for patient with seizure) 536 531 (99.1) 411 (77.4) 
Midazolam (for patient with seizure) 6111 6074 (99.4) 4909 (80.8) 
Diazepam (for patient with seizure) 271 269 (99.3) 210 (78.1) 
Morphine 1950 1945 (99.7) 1419 (73.0) 
Hydromorphone 140 140 (100.0) 109 (77.9) 
Fentanyl 16 755 16 595 (99.0) 13 782 (83.0) 
Ketorolac 505 505 (100) 381 (75.4) 
IM epinephrine (for patient with allergy or anaphylaxis) 1519 1413 (93) 1014 (71.8) 
Diphenhydramine (for patient with allergy or anaphylaxis) 3885 3861 (99.4) 3053 (79.1) 
Methylprednisolone 1664 1654 (99.4) 1339 (81.0) 
IV epinephrine 3125 3052 (97.7) 2315 (75.9) 
DrugTotal Number of PatientsNumber With Sufficient Data for Dose Calculation (%)Number With Available Weight for Dose Calculation (%)
Lorazepam (for patient with seizure) 536 531 (99.1) 411 (77.4) 
Midazolam (for patient with seizure) 6111 6074 (99.4) 4909 (80.8) 
Diazepam (for patient with seizure) 271 269 (99.3) 210 (78.1) 
Morphine 1950 1945 (99.7) 1419 (73.0) 
Hydromorphone 140 140 (100.0) 109 (77.9) 
Fentanyl 16 755 16 595 (99.0) 13 782 (83.0) 
Ketorolac 505 505 (100) 381 (75.4) 
IM epinephrine (for patient with allergy or anaphylaxis) 1519 1413 (93) 1014 (71.8) 
Diphenhydramine (for patient with allergy or anaphylaxis) 3885 3861 (99.4) 3053 (79.1) 
Methylprednisolone 1664 1654 (99.4) 1339 (81.0) 
IV epinephrine 3125 3052 (97.7) 2315 (75.9) 

The number with sufficient data for dose calculation indicates the presence of an available dose (including units) with an appropriately listed route. The number with an available wt calculation is the number of encounters with an available dose that also had a recorded wt.

When using encounters with a recorded weight, the overall consistency with national guidelines was 42.6 per 100 administrations. The medications with the highest and lowest proportion dosed consistently with national guidelines were methylprednisolone (75.1%), IM epinephrine (67.9%), and ketorolac (56.4%). The medications with the lowest proportion dosed consistently with national guidelines were diazepam (19.5%), lorazepam (21.2%), and morphine (23.2%) (Fig 2). Most deviations represented an underdose (ranging from 5.4% for IV epinephrine to 74.7% for lorazepam). Overdosing occurred less frequently. The medication most frequently overdosed was IV epinephrine (49.3%) and least frequently was morphine (3.0%). When evaluating differences based on route, a higher proportion of children given IV diazepam were underdosed compared with those given PR diazepam, who were more frequently overdosed (Fig 3). A higher proportion of children given intranasal and IM midazolam were underdosed compared with those given IV midazolam. Dosing with ketorolac was more frequently low when given IM compared with IV. Overdosing with diphenhydramine was more common when given IV compared with orally. When comparing between agency types, findings for both overall and specific drugs were similar. Community nonprofit organizations were accurate in 41.5% of the time, fire-based services were accurate 42.7% of the time, and government nonfire based services were accurate 46.7% of the time (Supplemental Table 4). When comparing mixed and nonvolunteer agency statuses, our findings were again similar between both (Supplemental Table 5).

FIGURE 2

Proportion of drug delivery to children in the prehospital setting classified as (1) within the recommended range, (2) inappropriately high, or (3) inappropriately low. Numbers in parenthesis indicate the total number of children receiving each medication. In (A), weight-based calculations are used for all pediatric EMS encounters with a weight in kilograms provided; in (B), estimations of weight were used for all patients using an age-based calculation.

FIGURE 2

Proportion of drug delivery to children in the prehospital setting classified as (1) within the recommended range, (2) inappropriately high, or (3) inappropriately low. Numbers in parenthesis indicate the total number of children receiving each medication. In (A), weight-based calculations are used for all pediatric EMS encounters with a weight in kilograms provided; in (B), estimations of weight were used for all patients using an age-based calculation.

Close modal
FIGURE 3

Differences in dosing for drugs by route on patients with a documented weight. Numbers in parenthesis indicate the total number of children receiving each medication. Hydromorphone not shown as only 1 patient received a dose of intramuscular hydromorphone.

FIGURE 3

Differences in dosing for drugs by route on patients with a documented weight. Numbers in parenthesis indicate the total number of children receiving each medication. Hydromorphone not shown as only 1 patient received a dose of intramuscular hydromorphone.

Close modal

Our overall findings were similar when estimating dosages from weights calculated by age. The overall consistency with national guidelines was 35.5 per 100 administrations. Underdosing again was more common. The medication underdosed most frequently was lorazepam (84.4%) and least frequently was IM epinephrine (13.1%). The medication most frequently overdosed was IV epinephrine (53.5%) and least frequently was lorazepam (2.1%). Our findings when evaluating differences in dosing based on route were similar when using these calculated weights to when using actual weights (Supplemental Fig 4).

When limiting our evaluation of IV epinephrine to patients with cardiac arrest, dosing was appropriate in 47.2%, too high in 48.4%, and too low in 4.4% among patients with a recorded weight (n = 1918). When using estimated weights for age (n = 2504), the dose was calculated to be appropriate in 29.8%, too high in 51.8%, and too low in 18.3%. Dosing deviations were similar among patients with steroids among those with a primary or secondary impression of an allergic reaction or anaphylaxis and those with a primary impression of asthma (Supplemental Fig 5).

We used a multiagency dataset to evaluate drug dosing for commonly used medications provided to children in the prehospital setting. There was substantial variance in weight-based dosing from national guidelines for commonly used pediatric medications. The extent of dosing deviation varied by medication, with some (diazepam, lorazepam, and morphine) having substantially more deviation than others (methylprednisolone, IM epinephrine, and ketorolac). These results were stable across common agency types and statuses and when using age-based weight estimation techniques. Our findings suggest the need for rigorous research and quality improvement efforts to improve guideline adherence and to minimize dosing errors.

There are likely several drivers for the observed deviation from national guidelines. First, some of the deviations represent differences in prehospital protocols across EMS systems compared with national guidelines. Such variations have previously been highlighted for the prehospital management of pediatric seizures30  and respiratory distress,31  and may explain why some medications had larger proportions of dosing deviations than others. For example, seizure medication dosing was consistently low compared with national guidelines. Dosing for midazolam across state guidelines varies widely, whereas some states use an IM dose of midazolam of 0.2 mg/kg, others use 0.1 mg/kg.30  Only 3 states at the time of that publication explicitly used the NASEMSO guidelines. Even within the NASEMSO guidelines, it may be challenging for EMS provider clinicians to rapidly identify appropriate pediatric drug dosages in real time, an issue that may carry over to many individual EMS agency protocols given the number of conditions encountered by EMS personnel.28,30,31  Although some EMS protocols are mandated statewide, others are optional, and some states do not provide any statewide guidance, leaving protocols to be developed locally. This finding suggests opportunities exist for improved education of EMS clinicians and EMS medical directors, along with opportunities to make EMS protocols more consistent with national guidelines.

Dosing errors are likely an additional driver for our findings. We build on existing knowledge of dosing variation found in prior regional or condition-specific research and in other pediatric care settings. In 1 study performed among 8 EMS agencies in Michigan, erroneous dosing occurred in 34.7% of administrations for 6 EMS-administered medications (albuterol, atropine, dextrose, diphenhydramine, epinephrine, and naloxone).24  A more recent study performed on the statewide Michigan EMS system similarly demonstrated that medications given with a high error rate included morphine, fentanyl, and midazolam, though the exact percentages of error were limited by low counts for some of these drugs.23  Other work has demonstrated a high proportion of dosing errors, specifically for seizure medications, with underdosing occurring more frequently than overdosing.19,20,22  In contrast, a systematic review of pediatric and neonatal intensive care settings identified a median rate of medication errors of 14.6%, a sizeable but lower proportion compared with the variance seen in the current study.35  Taken together, these findings suggest there may be even greater opportunities for improving dosing of pediatric medications in prehospital compared with in-hospital acute care settings.

We note differences in dosing deviations between drugs. Potentially, some of these findings may reflect hesitation among EMS clinicians or EMS medical directors to provide adequate dosing out of a concern for oversedation, a finding which may be reflected in the frequent underdosing of benzodiazepines and opioid medications.36  In contrast, other medications, such as ketorolac, epinephrine, and methylprednisolone were more frequently appropriately dosed compared with these medications. An approach to address this will require greater implementation of expert, consensus-based guidelines combined with greater efforts toward training paramedics on the appropriate use of potentially sedating medications.

To improve care delivery, a strategy that incorporates research, quality improvement, and implementation-science based approaches will be required. As findings were similar across agency types and statuses, a comprehensive approach is warranted to address these gaps. Additional research and implementation efforts are needed to evaluate and monitor common-sense practice changes. Qualitative research studies have suggested specific challenges in pediatric medication dosing that include difficulties in weight estimation, incorrect use of the Broselow tape, and difficulty with calculations during stressful situations.19  A position statement from the NAEMSP suggests a multimodal approach to address this issue, including utilizing dose-derivation strategies that avoid use of calculations, using kilograms as a weight standard, confirmation of weight at the time of drug delivery, improving training through simulations, and use of standardized formularies.37  One focus group study suggested that improvements can be made in simplifying dose delivery and that length-based tape, pediatric checklists, and dose cards may help reduce dosing errors.38  A study performed in one urban EMS system demonstrated that requiring clinicians to report the color zone (which provides a weight approximation) of the Broselow tape to the base station was associated with an improvement in the dosing of IV epinephrine for cardiac arrest.17  Another study by the same investigators showed that errors in antiseizure medications could be reduced through the implementation of standardized formularies with precalculated medication dosages.16  A similar approach with prefilled syringes has been demonstrated to be effective in pediatric resuscitation scenarios.39  Other investigators have reported success in the use of dedicated simulations or real-time aids to reduce dosing errors.18,20,40,41  Although the optimal strategy to improve dosing accuracy in the prehospital setting is uncertain, our findings identify a clear need for the implementation of such strategies to address substantial variance in dosing of medications for prehospital pediatric patients.

Our findings are subject to limitations. This was a retrospective study that used previously charted data, and therefore may be subject to inaccuracies with drug dosages, timing, route of administration or weight. The ESO dataset does not contain geographic data or protocol information to account for weight-based dosing guidelines within local EMS protocols that differed from NASEMSO or PALS guidelines. Weights in the dataset may be obtained through varying ways and may not have been known before the time of drug delivery. We attempted to mitigate this issue by using 2 approaches toward ideal weight-based dose calculation. Despite these limitations, our findings suggest important deviations in pediatric drug dosing using a large, multiagency dataset, demonstrating important research, implementation, and quality improvement needs.

Using a nationally representative prehospital dataset, we identified a wide range of deviations in dosing of medications administered to prehospital pediatric patients compared with guideline-recommended weight-based doses. This was greater for some drugs, such as diazepam, lorazepam, and morphine, than for others, and was notable across different agency types and statuses. As these findings may have multiple causes, including differences in protocols and errors in dosing, addressing these deviations should be a target for future educational, quality improvement, and research activities.

We thank ESO (Austin, TX) for provision of the data used in this study.

Dr Ramgopal conceptualized and designed the study, collected data, conducted the initial analyses, and drafted the initial manuscript; Dr Martin-Gill designed the study and contributed to data analysis; and both authors reviewed and revised the manuscript for important intellectual content, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.

FUNDING: No external funding.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

ALS

advanced life support

EMS

emergency medical services

IM

intramuscular

IV

intravenous

NAEMSP

National Association of EMS Physicians

NASEMSO

National Association of State EMS Officials

1
Ramgopal
S
,
Elmer
J
,
Escajeda
J
,
Martin-Gill
C
.
Differences in prehospital patient assessments for pediatric versus adult patients
.
J Pediatr
.
2018
;
199
:
200
205.e6
2
Seidel
JS
,
Hornbein
M
,
Yoshiyama
K
,
Kuznets
D
,
Finklestein
JZ
,
St Geme
JW
Jr
.
Emergency medical services and the pediatric patient: are the needs being met?
Pediatrics
.
1984
;
73
(
6
):
769
772
3
Ramgopal
S
,
Sepanski
RJ
,
Martin-Gill
C
.
Empirically derived age-based vital signs for children in the out-of-hospital setting
.
Ann Emerg Med
.
2022
;
81
(
22
):
402
412
4
Richard
J
,
Osmond
MH
,
Nesbitt
L
,
Stiell
IG
.
Management and outcomes of pediatric patients transported by emergency medical services in a Canadian prehospital system
.
CJEM
.
2006
;
8
(
1
):
6
12
5
Lerner
EB
,
Dayan
PS
,
Brown
K
, et al;
Pediatric Emergency Care Applied Research Network (PECARN)
.
Characteristics of the pediatric patients treated by the Pediatric Emergency Care Applied Research Network’s affiliated EMS agencies
.
Prehosp Emerg Care
.
2014
;
18
(
1
):
52
59
6
Stevens
SL
,
Alexander
JL
.
The impact of training and experience on EMS providers’ feelings toward pediatric emergencies in a rural state
.
Pediatr Emerg Care
.
2005
;
21
(
1
):
12
17
7
Hansen
M
,
Meckler
G
,
Dickinson
C
, et al
.
Children’s safety initiative: a national assessment of pediatric educational needs among emergency medical services providers
.
Prehosp Emerg Care
.
2015
;
19
(
2
):
287
291
8
Ward
CE
,
Singletary
J
,
Hatcliffe
RE
, et al
.
Emergency medical services clinicians’ perspectives on pediatric non-transport [published online ahead of print August 29, 2022]
.
Prehospital Emerg Care
.
doi: 10.1080/10903127.2022.2108180
9
Glaeser
PW
,
Linzer
J
,
Tunik
MG
,
Henderson
DP
,
Ball
J
.
Survey of nationally registered emergency medical services providers: pediatric education
.
Ann Emerg Med
.
2000
;
36
(
1
):
33
38
10
Jeruzal
JN
,
Boland
LL
,
Frazer
MS
, et al
.
Emergency medical services provider perspectives on pediatric calls: a qualitative study
.
Prehospital Emerg Care
.
2019
;
23
(
4
):
501
509
11
Owusu-Ansah
S
,
Moore
B
,
Shah
MI
, et al;
Committee on Pediatric Emergency Medicine, Section on Emergency Medicine
;
EMS Subcommittee, Section on Surgery
.
Pediatric readiness in emergency medical services systems
.
Pediatrics
.
2020
;
145
(
1
):
e20193308
12
Vasquez
A
,
Gaínza-Lein
M
,
Abend
NS
, et al;
Pediatric Status Epilepticus Research Group (pSERG)
.
First-line medication dosing in pediatric refractory status epilepticus
.
Neurology
.
2020
;
95
(
19
):
e2683
e2696
13
Ramgopal
S
,
Martin-Gill
C
.
Prehospital seizure management in children: an evaluation of a nationally representative sample
.
J Pediatr
.
2023
;
113379
14
Siefkes
HM
,
Holsti
M
,
Morita
D
,
Cook
LJ
,
Bratton
S
.
Seizure treatment in children transported to tertiary care: recommendation adherence and outcomes
.
Pediatrics
.
2016
;
138
(
6
):
e20161527
15
Nassif
A
,
Ostermayer
DG
,
Hoang
KB
,
Claiborne
MK
,
Camp
EA
,
Shah
MI
.
Implementation of a prehospital protocol change for asthmatic children
.
Prehosp Emerg Care
.
2018
;
22
(
4
):
457
465
16
Bosson
N
,
Kaji
AH
,
Gausche-Hill
M
.
A standardized formulary to reduce pediatric medication dosing errors: a mixed methods study
.
Prehosp Emerg Care
.
2022
;
26
(
4
):
492
502
17
Kaji
AH
,
Gausche-Hill
M
,
Conrad
H
, et al
.
Emergency medical services system changes reduce pediatric epinephrine dosing errors in the prehospital setting
.
Pediatrics
.
2006
;
118
(
4
):
1493
1500
18
Lammers
R
,
Willoughby-Byrwa
M
,
Fales
W
.
Medication errors in prehospital management of simulated pediatric anaphylaxis
.
Prehosp Emerg Care
.
2014
;
18
(
2
):
295
304
19
Lammers
R
,
Byrwa
M
,
Fales
W
.
Root causes of errors in a simulated prehospital pediatric emergency
.
Acad Emerg Med
.
2012
;
19
(
1
):
37
47
20
Shah
MI
,
Carey
JM
,
Rapp
SE
, et al
.
Impact of high-fidelity pediatric simulation on paramedic seizure management
.
Prehosp Emerg Care
.
2016
;
20
(
4
):
499
507
21
Lammers
RL
,
Willoughby-Byrwa
M
,
Fales
WD
.
Errors and error-producing conditions during a simulated, prehospital, pediatric cardiopulmonary arrest
.
Simul Healthc
.
2014
;
9
(
3
):
174
183
22
Shah
MI
,
Ostermayer
DG
,
Browne
LR
, et al
.
Multicenter evaluation of prehospital seizure management in children
.
Prehosp Emerg Care
.
2021
;
25
(
4
):
475
486
23
Kazi
R
,
Hoyle
JD
Jr
,
Huffman
C
, et al
.
An analysis of prehospital pediatric medication dosing errors after implementation of a state-wide EMS pediatric drug dosing reference [published online ahead of print February 1, 2023]
.
Prehospital Emerg Care
.
doi: 10.1080/10903127.2022.2162648
24
Hoyle
JD
Jr
,
Davis
AT
,
Putman
KK
,
Trytko
JA
,
Fales
WD
.
Medication dosing errors in pediatric patients treated by emergency medical services
.
Prehosp Emerg Care
.
2012
;
16
(
1
):
59
66
25
Rappaport
LD
,
Markowitz
G
,
Hulac
S
,
Roosevelt
G
.
Medication errors in pediatric patients after implementation of a field guide with volume-based dosing
.
Prehospital Emerg Care
.
2023
;
27
(
2
):
213
220
26
ESO
.
Data and research
.
Available at: https://www.eso.com/data-and-research/. Accessed October 14, 2022
27
American Heart Association
.
Pediatric Advanced Life Support Provider Manual
.
Dallas, TX
:
American Heart Association
;
2020
28
National Association of State EMS Officials
.
Model EMS clinical guidelines
.
29
Pediatric and Neonatal Lexi-Drugs Online
.
Lexicomp online
.
Available at: https://online.lexi.com. Accessed February 22, 2023
30
Ramgopal
S
,
McCans
K
,
Martin-Gill
C
,
Owusu-Ansah
S
.
Variation in prehospital protocols for pediatric seizure within the United States
.
Pediatr Emerg Care
.
2021
;
37
(
12
):
e1331
e1338
31
McCans
K
,
Varma
S
,
Ramgopal
S
,
Martin-Gill
C
,
Owusu-Ansah
S
.
Variation in prehospital protocols for pediatric respiratory distress management in the United States
.
Pediatr Emerg Care
.
2022
;
38
(
7
):
e1355
e1361
32
Tinning
K
,
Acworth
J
.
Make your best guess: an updated method for paediatric weight estimation in emergencies
.
Emerg Med Australas
.
2007
;
19
(
6
):
528
534
33
Marlow
RD
,
Lo
D
,
Walton
LJ
.
Accurate paediatric weight estimation by age: mission impossible?
Arch Dis Child
.
2011
;
96
(
1
):
A1
A2
34
Hoyle
JD
,
Ekblad
G
,
Hover
T
, et al
.
Dosing errors made by paramedics during pediatric patient simulations after implementation of a state-wide pediatric drug dosing reference
.
Prehospital Emerg Care
.
2020
;
24
(
2
):
204
213
35
Alghamdi
AA
,
Keers
RN
,
Sutherland
A
,
Ashcroft
DM
.
Prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care settings: a systematic review
.
Drug Saf
.
2019
;
42
(
12
):
1423
1436
36
Williams
DM
,
Rindal
KE
,
Cushman
JT
,
Shah
MN
.
Barriers to and enablers for prehospital analgesia for pediatric patients
.
Prehosp Emerg Care
.
2012
;
16
(
4
):
519
526
37
Cicero
MX
,
Adelgais
K
,
Hoyle
JD
, et al;
Pediatric Committee of NAEMSP adopted by NAEMSP Board of Directors
.
Medication dosing safety for pediatric patients: recognizing gaps, safety threats, and best practices in the emergency medical services setting. A position statement and resource document from NAEMSP
.
Prehosp Emerg Care
.
2021
;
25
(
2
):
294
306
38
Hoyle
JD
Jr
,
Sleight
D
,
Henry
R
,
Chassee
T
,
Fales
B
,
Mavis
B
.
Pediatric prehospital medication dosing errors: a mixed-methods study
.
Prehosp Emerg Care
.
2016
;
20
(
1
):
117
124
39
Stevens
AD
,
Hernandez
C
,
Jones
S
, et al
.
Color-coded prefilled medication syringes decrease time to delivery and dosing errors in simulated prehospital pediatric resuscitations: a randomized crossover trial
.
Resuscitation
.
2015
;
96
:
85
91
40
Keene
JC
,
Woods
B
,
Wainwright
M
,
King
M
,
Morgan
LA
.
Optimized benzodiazepine treatment of pediatric status epilepticus through a standardized emergency medical services resuscitation tool
.
Pediatr Neurol
.
2022
;
126
:
50
55
41
Bernius
M
,
Thibodeau
B
,
Jones
A
,
Clothier
B
,
Witting
M
.
Prevention of pediatric drug calculation errors by prehospital care providers
.
Prehosp Emerg Care
.
2008
;
12
(
4
):
486
494

Supplementary data